Jh. Cheng et al., Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ currentin rabbit ventricular myocytes, EUR J PHARM, 376(1-2), 1999, pp. 189-201
Carvedilol ((+/-)-1-(carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]
-2-propanol), a beta-adrenoceptor-blocking agent with vasodilator propertie
s, has been reported to produce dose-related improvements in left ventricul
ar function and reduction in mortality in patients with chronic heart failu
re. However, its electrophysiological effects have not been elucidated. We
studied ion channel and action potential modulation by carvedilol in rabbit
ventricular preparations using whole-cell voltage-clamp and standard micro
electrode techniques. In ventricular myocytes, carvedilol blocked the rapid
ly activating component of the delayed rectifier K+ current (I-Kr) in a con
centration-dependent manner (IC50 = 0.35 mu M). This block was voltage- and
time-independent; a prolongation of the depolarizing pulses from a holding
potential of -50 mV to +10 mV within the range of 100-3000 ms did not affe
ct the extent of I-Kr block. Carvedilol also inhibited the L-type Ca2+ curr
ent (I-Ca), the transient outward K+ current (I-to) and the slowly activati
ng component of the delayed rectifier K+ current (I-Ks) with IC50 of 3.59,
3.34, and 12.54 mu M, respectively. Carvedilol (0.3-30 mu M) had no signifi
cant effects on the inward rectifier K+ current. In papillary muscles from
rabbits pretreated with reserpine, action potential duration was prolonged
by 7-12% with 1 mu M and by 12-24% with 3 mu M carvedilol at stimulation fr
equencies of 0.1-3.0 Hz. No further action potential duration prolongation
was observed at concentrations higher than 3 mu M. These results suggest th
at concomitant block of K+ and Ca2+ currents by carvedilol resulted in a mo
derate prolongation of action potential duration with minimal reverse frequ
ency-dependence. Such electrophysiological effects of carvedilol would be b
eneficial in the treatment of ventricular tachyarrhythmias. (C) 1999 Elsevi
er Science B.V. All rights reserved.